speb/financial-data huggingface dataset:
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -26300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 5731900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 26140800000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 5667700000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 71600000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1980800000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 1483500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Operating Income: 1332600000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 7985100000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1837700000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 464900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 28871800000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2485600000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Investments: 1739200000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 91200000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 120200000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 213700000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1110000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 5547700000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 39900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 8171800000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Payables: 4219000000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 1501800000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2313700000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 452700000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1563900000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1563900000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 29308300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 26140800000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 18300000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.01
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 5300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 36710500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 29308300000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 719600000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 29293500000.00
EMAMILTD.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 6652500000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7417000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 18126000000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 631800000.00
EMAMILTD.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 11799300000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 4746700000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 11518100000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Amortization: 230400000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 436448087.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 7.32
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3382600000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 453200000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 222800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 436448087.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 7.32
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3194800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — EBIT: 3479700000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — EBITDA: 3932900000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 8135500000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 29200000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 29200000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Income: 3194800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3194800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3194800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3194800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3194800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3194800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -29200000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -29200000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4034400000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 3288778321.98
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Operating Income: 3388800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 11518100000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 189700000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1167800000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 101500000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 3450500000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3382600000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 453200000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1911100000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1911100000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -101500000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -7521678.02
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 255700000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.07
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 8129300000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -101500000.00
EMAMILTD.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -101500000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — +Operating Expense: 18551900000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 4887300000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — +Total Revenue: 37795100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 9251000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 4770600000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4770600000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 3433200000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3433200000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Amortization: 884500000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Amortization: 195900000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 2872500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 2872500000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 436524390.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 3.28
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1046300000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -433200000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 395400000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 395400000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1767500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1767500000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9546000000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9546000000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -5238000000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -914700000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -707400000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Change In Payable: 337200000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 1165400000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 85800000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 649000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Common Stock: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 29239800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 29239800000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 7900000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 7900000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 11380100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2919200000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Current Assets: 19348600000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 19348600000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 154200000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 154200000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1223800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1223800000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1378000000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1378000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 192400000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 192400000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 8382400000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 8382400000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 990400000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 990400000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Depreciation: 1773400000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 1773400000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1773400000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 422500000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 888900000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 226600000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 436524390.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.28
EMAMILTD.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 7752700000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1431800000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 12700000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — EBIT: 8572000000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — EBIT: 1672200000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — EBITDA: 10345400000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — EBITDA: 2094700000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 72200000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1767500000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -5544900000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 7572100000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -436400000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -10300000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 681900000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2755800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2755800000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 5721800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5721800000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Gross Profit: 26415000000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 6331800000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Interest Expense: 111300000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 31500000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 111300000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 31500000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -114000000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 173700000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Inventory: 3995700000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 3995700000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 30463600000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 30463600000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1811400000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 400700000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 400700000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 2872500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 2872500000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 750000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 241200000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 241200000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 241200000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 241200000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 865900000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 865900000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 313500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 313500000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Minority Interest: -15400000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: -15400000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Minority Interests: 100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 100000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -40000000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Income: 7752700000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Income: 1431800000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 7752700000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1431800000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 7752600000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1431700000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 7752700000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1431800000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7752700000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1431800000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 8460700000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 7752600000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1431700000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Interest Income: -111300000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -31500000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1373900000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 603000000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -111300000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -31500000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -593700000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Net PPE: 5721800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 5721800000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -303900000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 603000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 26484000000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 26484000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 6261700000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 6261700000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 59300000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 59300000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 10446900000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2094700000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Normalized Income: 7845705176.88
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1431800000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 8005300000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Operating Income: 7863100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Operating Income: 1444500000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Operating Revenue: 37795100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 9251000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 436500000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 2134600000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2134600000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 384700000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 384700000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 28803300000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 28803300000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 2073900000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2073900000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -197200000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 89900000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 89900000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 111500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 111500000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 851100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 231800000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4595400000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1175600000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Properties: 5713900000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 5713900000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 231900000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 231900000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 7778500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 7778500000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Other Special Charges: 101500000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Payables: 4770600000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Payables: 4770600000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Pretax Income: 8460700000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1640700000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 1400000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -40000000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -32503700000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -433200000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 11380100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2919200000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1773400000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 422500000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -147000000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 31129800000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 129300000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 7392200000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 2119700000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 7392200000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2119700000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Share Issued: 436500000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 436500000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 750000000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -147000000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Special Income Charges: -101500000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 0.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 29239800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 29239800000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 26484000000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 26484000000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -8494823.12
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Tax Provision: 708100000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 209000000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.08
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.13
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 7200000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 7200000.00
EMAMILTD.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1719000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Total Assets: 38364400000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 38364400000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 29239800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 29239800000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1619200000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1619200000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 29224400000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 29224400000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Total Expenses: 29932000000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 7806500000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 9140000000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 9140000000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 19015800000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 19015800000.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 757600000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 757600000.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -101500000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
EMAMILTD.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -101500000.00
EMAMILTD.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
EMAMILTD.NS balance_sheet (annual, 2026-03-31) — Working Capital: 10966200000.00
EMAMILTD.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 10966200000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — +Operating Expense: 3721000000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — +Total Revenue: 19388400000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 1588100000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 2176600000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -4044400000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 179300000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -400000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 486800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 60500000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Basic EPS: 18.17
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 119200000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 3077800000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -349700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 0.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 2556200000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 1600000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 1600000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -98000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 1000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 600000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -45900000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 2100000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Change In Payable: 434900000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -351300000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 39800000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -117600000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Common Stock: 121000000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -98000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 4095000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 327700000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 13201600000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Current Assets: 5275100000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 0.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Current Debt: 4380300000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 4380300000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 6350400000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 36600000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Defined Pension Benefit: 0.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Depreciation: 738800000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 738800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 738800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 738800000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 0.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 79400000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Diluted EPS: 14.45
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 1099000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 700000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 7500000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — EBIT: 2179200000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — EBITDA: 2918000000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — End Cash Position: 1600000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -3067700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 159000000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 2937800000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: 11800000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -1900000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 47600000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2177000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 15985300000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Gross Profit: 6186800000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 0.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Interest Expense: 645300000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 645300000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Interest Income: 3500000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 3500000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -777000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Inventory: 2271000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 11951000000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -337400000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 486800000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 800000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 195100000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 0.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 3475700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 3475700000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 800000000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -2248100000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 164000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 12384700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Net Debt: 7854400000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 64600000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Income: 1148000000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 1099000000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 1148000000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 1148000000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 1148000000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 1533900000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 1148000000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Interest Income: -737700000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -2188900000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -1448100000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -737700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Net PPE: 11940900000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -344900000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -740800000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 6529700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 38500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1151700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 164000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 76800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 2975100000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Normalized Income: 1190734728.47
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 3287500000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Operating Income: 2465800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Operating Revenue: 19388400000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 60499050.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 32000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 97500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 3974000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 51200000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 883500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 8000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 38500000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 6400000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 1549300000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Payable: 59500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Properties: 11613200000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 82500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 15200000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Other Special Charges: 57100000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Payables: 1648300000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 27900000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 38900000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Preferred Stock: 2435200000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Preferred Stock Dividends: 49000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Preferred Stock Equity: 2435200000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 512200000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Pretax Income: 1533900000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -400000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -349700000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1992900000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 13201600000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 738800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 6500000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 6500000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -2248100000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 15900000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1996900000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 4800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 776700000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 824300000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Share Issued: 60499050.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Special Income Charges: -57100000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 6530200000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 4094500000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -14365271.53
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Tax Provision: 385900000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.25
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 215300000.00
EMAMIPAP.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -10500000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Total Assets: 17789400000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 10005900000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Total Debt: 7856000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 6530200000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Total Expenses: 16922600000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 11259200000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 12514300000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 4908800000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 95900000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -57100000.00
EMAMIPAP.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -57100000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 10000000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Work In Process: 67900000.00
EMAMIPAP.NS balance_sheet (annual, 2022-03-31) — Working Capital: -1075300000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — +Operating Expense: 4608800000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — +Total Revenue: 23707300000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 2092500000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 2625700000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4690700000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 179300000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -1000000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 200000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 388500000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 60500000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Basic EPS: 10.62
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1600000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 3095800000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -261500000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 0.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 2556200000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1200000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2000000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -145800000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 1200000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -1817100000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 13700000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Change In Payable: 476800000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -556800000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1883400000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -400000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Common Stock: 121000000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -145800000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4552000000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 63900000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 17426100000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Current Assets: 7758800000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Current Debt: 5831400000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 5831400000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 8428400000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 37000000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Depreciation: 675700000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 675900000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 675900000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 675900000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 0.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 79400000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Diluted EPS: 8.71
EMAMIPAP.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 642700000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 700000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 7500000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — EBIT: 1479300000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — EBITDA: 2155200000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — End Cash Position: 1200000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -89800000.00
EMAMIPAP.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 254100000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 63100000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 9900000.00
EMAMIPAP.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -1200000.00
EMAMIPAP.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 54600000.00